Respiratory Pathology — MCQs

A 29-year-old man with no significant past medical history presents with acute onset hemoptysis. On physical examination, his vital signs are: temperature 37°C, pulse 83/min, respirations 28/min, and blood pressure 150/95 mm Hg. A chest radiograph reveals bilateral fluffy infiltrates. Microscopic examination of a transbronchial lung biopsy shows focal necrosis of alveolar walls accompanied by significant intra-alveolar hemorrhage. Two days later, he develops oliguria, with a serum creatinine level of 2.9 mg/dL and urea nitrogen of 31 mg/dL. Which of the following antibodies is most likely involved in the pathogenesis of his condition?

Q40Medium

All of the following are true regarding histological features of asbestosis, except:

Respiratory Pathology Indian Medical PG Practice Questions and MCQs

Question 31: A 56-year-old chronic smoker has a mass resected from the bronchus. What is the most useful immunohistochemical marker for a proper diagnosis?

A. Cytokeratin (Correct Answer)
B. Vimentin
C. Epithelial membrane antigen
D. Leukocyte common antigen

Explanation: **Explanation:** The clinical presentation of a **56-year-old chronic smoker** with a **bronchial mass** is highly suggestive of **Bronchogenic Carcinoma** (most commonly Squamous Cell Carcinoma or Small Cell Carcinoma) [1]. To confirm the diagnosis of a carcinoma, one must demonstrate its epithelial origin [3]. 1. **Why Cytokeratin (CK) is correct:** Cytokeratins are intermediate filaments found specifically in the intracytoplasmic cytoskeleton of **epithelial cells**. Since almost all lung cancers (except rare sarcomas or lymphomas) are carcinomas, CK is the primary screening marker used to confirm that a tumor is epithelial in origin. 2. **Why other options are incorrect:** * **Vimentin:** This is an intermediate filament characteristic of **mesenchymal cells**. It is used to identify sarcomas, melanomas, or renal cell carcinomas (which can co-express CK and Vimentin). * **Epithelial Membrane Antigen (EMA):** While EMA is expressed in many epithelia, it is less specific than Cytokeratin and can be found in certain plasma cell tumors and lymphomas (e.g., Anaplastic Large Cell Lymphoma). * **Leukocyte Common Antigen (LCA/CD45):** This is the definitive marker for **hematolymphoid malignancies** (lymphomas/leukemias). It would be used if the differential diagnosis included a primary pulmonary lymphoma. **High-Yield Clinical Pearls for NEET-PG:** * **TTF-1 (Thyroid Transcription Factor-1):** The most specific marker for **Adenocarcinoma** of the lung and Small Cell Carcinoma. * **p40 / p63:** The gold standard markers for **Squamous Cell Carcinoma** [2]. * **Chromogranin / Synaptophysin:** Markers for **Neuroendocrine tumors** (Small Cell and Carcinoid) [3]. * **Calretinin:** The most specific marker for **Mesothelioma** (pleural tumor). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 721-723. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 336-337. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 337-338.

Question 32: A 72-year-old man presents with a year of increasing dyspnea. Auscultation reveals decreased breath sounds on the right side of the chest. A chest radiograph shows a large pleural mass encasing the right lung. Exposure to which of the following metals is most likely associated with these findings?

A. Arsenic
B. Asbestos (Correct Answer)
C. Beryllium
D. Chromium

Explanation: ### Explanation **Correct Option: B. Asbestos** The clinical presentation of a **large pleural mass encasing the lung** in an elderly patient is a classic description of **Malignant Mesothelioma** [3]. Asbestos exposure is the primary risk factor for this malignancy, with a long latent period of often about 30 years [3]. * **Pathology:** Mesothelioma typically starts in the pleura and spreads to surround the lung [2], creating a thick, gelatinous, gray-pink "rind" or "sheath" that restricts lung expansion. * **Microscopy:** It can show epithelioid, sarcomatoid, or biphasic patterns [1]. Calretinin and WT-1 are key immunohistochemical markers [1]. **Analysis of Incorrect Options:** * **A. Arsenic:** Exposure is primarily associated with **Squamous Cell Carcinoma** of the lung and skin cancers (e.g., Bowen’s disease, angiosarcoma of the liver), but not specifically pleural mesothelioma. * **C. Beryllium:** Causes **Berylliosis**, a chronic granulomatous disease that mimics Sarcoidosis (non-caseating granulomas). It increases the risk of bronchogenic carcinoma but not pleural masses. * **D. Chromium:** Hexavalent chromium exposure is a risk factor for **Bronchogenic Carcinoma** (small cell and squamous cell) and nasal cavity cancers, but it does not target the pleura. **High-Yield Clinical Pearls for NEET-PG:** * **Most Common Cancer in Asbestos Exposure:** Although asbestos is the only risk factor for mesothelioma, the most common cancer associated with asbestos exposure is actually **Bronchogenic Carcinoma** [2]. * **Synergy:** Smoking significantly increases the risk of bronchogenic carcinoma in asbestos workers but does **not** increase the risk of mesothelioma. * **Radiology:** Look for "Pleural Plaques" (most common manifestation) and "Holly Leaf" appearance on X-ray [2]. * **Ferruginous Bodies:** Asbestos bodies (golden-brown, fusiform rods with translucent centers) visualized with Prussian Blue stain. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, p. 731. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, p. 699. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 339-340.

Question 33: Which statement is FALSE regarding adenocarcinoma of the lung?

A. Accounts for 32% of lung carcinomas
B. Has the same incidence in males and females
C. Is typically located in the periphery of the lung
D. None of the above statements are false (Correct Answer)

Explanation: **Explanation** Adenocarcinoma is currently the most common histological subtype of primary lung cancer. This question tests the fundamental epidemiological and pathological characteristics of the disease. * **Option A (Incidence):** Adenocarcinoma accounts for approximately **32% to 40%** of all lung carcinomas. It has overtaken squamous cell carcinoma as the most frequent subtype in most populations. * **Option B (Gender Distribution):** Unlike squamous cell and small cell carcinomas, which show a strong male predominance due to historical smoking patterns, adenocarcinoma has a nearly **equal incidence in males and females**. Notably, it is the most common type of lung cancer in **non-smokers** and women. * **Option C (Location):** Adenocarcinoma is characteristically located in the **periphery** of the lung (subpleural), often arising in relation to peripheral scars [1]. In contrast, squamous cell and small cell carcinomas are typically central/hilar in origin. Since all three statements (A, B, and C) are medically accurate, **Option D** is the correct choice. **NEET-PG High-Yield Pearls:** * **Driver Mutations:** Frequently associated with **EGFR** mutations (especially in non-smoking Asian females), **ALK** rearrangements, and **KRAS** mutations (more common in smokers) [1]. * **Precursor Lesion:** Atypical Adenomatous Hyperplasia (AAH) → Adenocarcinoma in situ (AIS, formerly Bronchioloalveolar carcinoma) → Minimally Invasive Adenocarcinoma (MIA) [1]. * **Histology:** Shows gland formation and/or mucin production. Positive for **TTF-1** (Thyroid Transcription Factor-1) and **Napsin A** on immunohistochemistry. * **Clinical Feature:** Because of its peripheral location, it often presents with pleural involvement or chest wall pain rather than early hemoptysis. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 335-337.

Question 34: Schaumann bodies are seen in which of the following conditions?

A. Sarcoidosis (Correct Answer)
B. Chronic bronchitis
C. Asthma
D. Syphilis

Explanation: **Explanation:** **Schaumann bodies** are laminated, basophilic concretions composed of calcium and proteins. They are a classic histopathological hallmark of **Sarcoidosis**, a multisystem disorder characterized by non-caseating granulomas [1]. Within these granulomas, multinucleated giant cells (Langhans or foreign-body type) often contain these inclusions, along with **Asteroid bodies** (star-shaped eosinophilic inclusions) [2]. **Analysis of Options:** * **A. Sarcoidosis (Correct):** The presence of Schaumann bodies and Asteroid bodies within non-caseating granulomas is highly characteristic of Sarcoidosis, though not pathognomonic (they can occasionally be seen in Berylliosis) [2]. * **B. Chronic Bronchitis:** This is characterized by Reid Index elevation and goblet cell hyperplasia, not granulomatous inclusions. * **C. Asthma:** Key pathological findings include **Curschmann spirals** (mucus plugs), **Charcot-Leyden crystals** (eosinophil-derived), and Creola bodies. * **D. Syphilis:** This is characterized by **Gummas** (a form of necrotic granuloma) and obliterative endarteritis, but Schaumann bodies are not a feature. **NEET-PG High-Yield Pearls:** 1. **Sarcoidosis Triad:** Bilateral hilar lymphadenopathy, skin lesions (Lupus pernio), and eye involvement (Uveitis) [1]. 2. **Inclusions in Sarcoidosis:** * **Schaumann bodies:** Calcium/Protein (Basophilic). * **Asteroid bodies:** Entrapped cytoskeleton/lipids (Eosinophilic). 3. **Kveim-Siltzbach Test:** A historical skin test used for Sarcoidosis diagnosis (now largely replaced by biopsy and ACE levels). 4. **Elevated Markers:** Serum ACE (Angiotensin-Converting Enzyme) and hypercalcemia/hypercalciuria are common due to 1-alpha-hydroxylase activity in macrophages. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 700-701. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 198-200.

Question 35: Which of the following is NOT a histological feature of pulmonary hypertension?

A. Capillaritis of alveolar septa
B. Saddle thrombi in pulmonary trunk
C. Thrombi in pulmonary vasculature (Correct Answer)
D. All of the above

Explanation: **Explanation:** The question asks for a feature that is **NOT** a histological hallmark of pulmonary hypertension (PH). **1. Why "Thrombi in pulmonary vasculature" is the correct answer:** In the context of standard pathology textbooks (like Robbins), the characteristic histological changes of PH involve **remodeling** of the vessel wall rather than simple thrombosis. While "thrombotic lesions" (organized thrombi) can occur in Chronic Thromboembolic Pulmonary Hypertension (CTEPH), the primary histological hallmarks of idiopathic PH are **plexiform lesions**, medial hypertrophy, and intimal fibrosis [1]. In many standardized exams, "thrombi" is considered a *cause* or a *complication* rather than a primary histological feature of the hypertensive remodeling process itself. **2. Analysis of other options:** * **Capillaritis of alveolar septa:** This is a feature of **diffuse alveolar hemorrhage syndromes** (like Wegener’s or Goodpasture’s), not pulmonary hypertension [1]. Therefore, it is technically not a feature of PH. * **Saddle thrombi in pulmonary trunk:** This is a macroscopic finding associated with **acute massive pulmonary embolism**, which causes sudden death or acute cor pulmonale, but it is not a microscopic/histological feature of chronic pulmonary hypertension [2]. *(Note: There appears to be a discrepancy in the provided key; typically, if A and B are also incorrect, the answer should be "All of the above." However, focusing on the histological "remodeling" aspect, thrombi are often excluded from the classic triad of PH histology.)* **Clinical Pearls for NEET-PG:** * **Plexiform Lesions:** The pathognomonic histological feature of advanced primary pulmonary hypertension (Grade IV Heath-Edwards) [1]. * **Heath-Edwards Grading:** A 6-stage system used to grade the severity of PH based on vascular changes (Medial hypertrophy → Intimal fibrosis → Plexiform lesions → Necrotizing arteritis). * **BMPR2 Mutation:** The most common genetic association with heritable pulmonary arterial hypertension. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 707-708. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 137-138.

Question 36: Cough and sputum in COPD are primarily due to changes in which part of the respiratory system?

A. Large airways (Correct Answer)
B. Medium airways
C. Small airways
D. Lung parenchyma

Explanation: **Explanation:** The hallmark of Chronic Obstructive Pulmonary Disease (COPD), specifically chronic bronchitis, is hypersecretion of mucus [1]. This occurs primarily in the **large airways** (trachea and bronchi). **1. Why Large Airways is Correct:** The primary pathological change responsible for cough and sputum production is the **hyperplasia of mucus-secreting goblet cells** and the **hypertrophy of submucosal glands** [2]. These glands are anatomically located in the large airways. The **Reid Index** (ratio of the thickness of the mucous gland layer to the thickness of the wall between the epithelium and the cartilage) increases in chronic bronchitis, directly correlating with the severity of sputum production [2]. **2. Why Incorrect Options are Wrong:** * **Medium Airways:** While affected by inflammation, they are not the primary site for the glandular hypertrophy that drives chronic sputum production. * **Small Airways (Bronchioles):** This is the site of **early airflow obstruction** (bronchiolitis obliterans) [2]. While critical in COPD pathogenesis, changes here lead to airway narrowing and increased resistance rather than significant sputum production. * **Lung Parenchyma:** This is the site of **Emphysema**. Damage here involves the destruction of alveolar walls and permanent enlargement of airspaces, leading to loss of elastic recoil and dyspnea, not primary cough/sputum [3]. **Clinical Pearls for NEET-PG:** * **Definition of Chronic Bronchitis:** Productive cough for at least **3 months** in at least **2 consecutive years**. * **Reid Index:** Normal is < 0.4. In chronic bronchitis, it is typically > 0.5. * **Small Airway Disease:** Often referred to as the "silent zone" because significant damage can occur before symptoms or spirometry changes appear. * **Centriacinar Emphysema:** Most common type in smokers; primarily affects the upper lobes [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 308-310. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 685-686. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 684-685.

Question 37: In a chronic smoker, which highly malignant, aggressive, and metastatic lung carcinoma is most commonly seen?

A. Squamous cell Carcinoma
B. Adenocarcinoma
C. Large cell carcinoma
D. Small cell Carcinoma (Correct Answer)

Explanation: **Explanation:** **Small Cell Carcinoma (SCLC)** is the correct answer because it is the most aggressive of all lung cancers, characterized by a rapid doubling time, early widespread metastasis [1], and an almost exclusive association with heavy smoking (>95% of cases). It originates from neuroendocrine cells (Kulchitsky cells) and is typically centrally located [1]. Due to its high malignancy, it is usually disseminated at the time of diagnosis and is treated primarily with chemotherapy rather than surgery [3]. **Analysis of Incorrect Options:** * **Squamous Cell Carcinoma:** Also strongly associated with smoking and centrally located, but it is generally slower-growing and metastasizes later than SCLC [2]. It is characterized by keratin pearls and intercellular bridges [2]. * **Adenocarcinoma:** This is the most common type of lung cancer overall and the most common in non-smokers/women. It is typically peripheral and follows a less aggressive initial course compared to SCLC [2]. * **Large Cell Carcinoma:** An undifferentiated malignant epithelial tumor that lacks the features of other types [1]. While aggressive, it does not match the specific neuroendocrine profile or the extreme metastatic potential of SCLC. **High-Yield Clinical Pearls for NEET-PG:** * **Location:** SCLC and Squamous Cell are **Central** (Sentral); Adenocarcinoma and Large Cell are **Peripheral**. * **Paraneoplastic Syndromes:** SCLC is classically associated with **SIADH** (ADH secretion), **Cushing Syndrome** (ACTH), and **Lambert-Eaton Myasthenic Syndrome** [3]. * **Histology:** Look for "Oat cell" appearance, scant cytoplasm, nuclear molding, and the **Azzopardi effect** (DNA staining of vessel walls) [1]. * **Markers:** Positive for neuroendocrine markers like **Chromogranin A, Synaptophysin, and CD56** [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 337-338. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 336-337. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 725-727.

Question 38: Alpha-1 antitrypsin deficiency occurs in which of the following conditions?

A. Emphysema (Correct Answer)
B. Bronchiectasis
C. Empyema
D. Bronchogenic carcinoma

Explanation: **Explanation:** **Alpha-1 Antitrypsin (AAT) Deficiency** is a genetic disorder characterized by low levels of AAT, a protease inhibitor synthesized in the liver [2]. Its primary role is to inhibit **Neutrophil Elastase**, an enzyme that breaks down elastin in the alveolar walls [1]. **Why Emphysema is Correct:** In AAT deficiency, the lack of protective antiprotease allows neutrophil elastase to destroy the elastic tissue of the lung parenchyma unchecked [1]. This leads to the permanent enlargement of airspaces distal to the terminal bronchioles, known as **Panacinar Emphysema** [3]. This typically affects the **lower lobes** of the lungs and often manifests in non-smokers or young adults [1]. **Why Other Options are Incorrect:** * **Bronchiectasis:** This is a chronic necrotizing infection of the bronchi and bronchioles leading to abnormal permanent dilation of airways. While it can coexist with advanced COPD, it is not the primary pathology caused by AAT deficiency. * **Empyema:** This refers to a collection of pus within the pleural cavity, usually secondary to bacterial pneumonia or lung abscess. It is an infectious process, not a genetic protease-antiprotease imbalance. * **Bronchogenic Carcinoma:** While chronic lung inflammation increases cancer risk, AAT deficiency is not a direct cause of bronchogenic carcinoma. Its primary extra-pulmonary manifestation is **Liver Cirrhosis** (due to misfolded protein accumulation in hepatocytes) [2]. **NEET-PG High-Yield Pearls:** 1. **Genetics:** Autosomal codominant inheritance; the most common severe deficient phenotype is **PiZZ** [1]. 2. **Morphology:** Emphysema in AAT deficiency is **Panacinar** (affects the entire acinus), whereas smoking-related emphysema is typically **Centriacinar** (upper lobes) [3]. 3. **Liver Pathology:** Characterized by **PAS-positive, diastase-resistant** eosinophilic globules in periportal hepatocytes. 4. **Clinical Clue:** Suspect AAT deficiency in a young patient (30–45 years) presenting with emphysema and/or unexplained liver cirrhosis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 683-684. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 856-858. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 684-685.

Question 39: A 29-year-old man with no significant past medical history presents with acute onset hemoptysis. On physical examination, his vital signs are: temperature 37°C, pulse 83/min, respirations 28/min, and blood pressure 150/95 mm Hg. A chest radiograph reveals bilateral fluffy infiltrates. Microscopic examination of a transbronchial lung biopsy shows focal necrosis of alveolar walls accompanied by significant intra-alveolar hemorrhage. Two days later, he develops oliguria, with a serum creatinine level of 2.9 mg/dL and urea nitrogen of 31 mg/dL. Which of the following antibodies is most likely involved in the pathogenesis of his condition?

A. Anti-DNA topoisomerase I antibody
B. Anti-glomerular basement membrane antibody (Correct Answer)
C. Antimitochondrial antibody
D. Anti-neutrophil cytoplasmic antibody

Explanation: ### Explanation The clinical presentation of **hemoptysis** (lung hemorrhage) followed by **acute renal failure** (oliguria and elevated creatinine) in a young male is the classic "Pulmonary-Renal Syndrome." **1. Why the Correct Answer is Right:** The patient likely has **Goodpasture Syndrome**. This condition is caused by **Anti-glomerular basement membrane (Anti-GBM) antibodies** directed against the non-collagenous domain of the **α3 chain of Type IV collagen** [1]. * **Pathogenesis:** These antibodies cross-react with the basement membranes of both the renal glomeruli and the pulmonary alveoli [2]. * **Morphology:** In the lungs, this leads to necrotizing hemorrhagic interstitial pneumonitis (fluffy infiltrates). In the kidneys, it causes a **Rapidly Progressive Glomerulonephritis (RPGN Type I)**, characterized by linear IgG deposits on immunofluorescence [1]. **2. Why the Incorrect Options are Wrong:** * **A. Anti-DNA topoisomerase I (Anti-Scl-70):** Associated with Diffuse Systemic Sclerosis. While it causes pulmonary fibrosis, it does not typically present with acute hemoptysis and RPGN. * **C. Antimitochondrial antibody (AMA):** The hallmark of Primary Biliary Cholangitis; unrelated to pulmonary-renal syndromes. * **D. Anti-neutrophil cytoplasmic antibody (ANCA):** Associated with Small Vessel Vasculitis (e.g., Granulomatosis with Polyangiitis) [3]. While GPA also presents with pulmonary-renal symptoms, it usually involves the upper respiratory tract (sinusitis) and shows **pauci-immune** (no antibody deposition) patterns rather than anti-GBM activity [3]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Immunofluorescence Pattern:** Goodpasture Syndrome shows a **characteristic linear pattern** of IgG and C3 deposition. * **Demographics:** Typically affects young men (20s) or older women (60s) [1]. * **Treatment:** Plasmapheresis (to remove circulating antibodies) and immunosuppression [1]. * **Key Distinction:** If only the kidney is involved, it is called "Anti-GBM Glomerulonephritis"; if both lung and kidney are involved, it is "Goodpasture Syndrome" [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 537-538. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 322-323. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 917-918.

Question 40: All of the following are true regarding histological features of asbestosis, except:

A. Diffuse pulmonary interstitial fibrosis
B. Asbestos bodies consist of asbestos fibers coated with a proteinaceous material (Correct Answer)
C. Fibrosis begins around respiratory bronchioles and alveolar ducts and extends to involve adjacent alveolar sacs and alveoli
D. Pleural plaques are collections of dense collagen

Explanation: ### Explanation **1. Why Option B is the correct answer (The "Except" statement):** Asbestos bodies are not merely coated with proteinaceous material; they are specifically coated with **iron-containing proteinaceous material (ferritin and hemosiderin)**. Because of this iron coating, they appear as golden-brown, beaded, or dumbbell-shaped rods and are more accurately termed **Ferruginous bodies**. In the NEET-PG context, remember that while all asbestos bodies are ferruginous bodies, not all ferruginous bodies are asbestos (other inorganic particles can also be coated with iron). **2. Analysis of Incorrect Options:** * **Option A:** Asbestosis is characterized by **diffuse pulmonary interstitial fibrosis**, similar to idiopathic pulmonary fibrosis (IPF), but distinguished by the presence of asbestos bodies [1]. * **Option C:** The fibrotic process typically **begins around respiratory bronchioles and alveolar ducts**. As the disease progresses, it extends to involve adjacent alveolar sacs and alveoli, eventually leading to a "honeycomb lung" appearance in advanced stages. * **Option D:** **Pleural plaques** are the most common manifestation of asbestos exposure [1]. They consist of circumscribed patches of **dense, pearly-white collagen**, most frequently found on the parietal pleura and the domes of the diaphragm [3]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Lower Lobe Predominance:** Unlike silicosis and coal worker's pneumoconiosis (CWP) which affect upper lobes, asbestosis primarily involves the **lower lobes** [1]. * **Malignancy:** Asbestos exposure increases the risk of both **Bronchogenic Carcinoma** and **Mesothelioma** [2]. However, Bronchogenic Carcinoma is the *most common* cancer associated with asbestos, especially in smokers. * **Prussian Blue Stain:** This stain is used to highlight the iron coating of asbestos bodies, making them appear blue. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 698-699. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, p. 699. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 339-340.

Practice by Chapter

Congenital Anomalies

Practice Questions

Atelectasis and Acute Lung Injury

Practice Questions

Obstructive Pulmonary Diseases

Practice Questions

Restrictive Pulmonary Diseases

Practice Questions

Lung Infections

Practice Questions

Pulmonary Vascular Diseases

Practice Questions

Lung Tumors

Practice Questions

Pleural Diseases

Practice Questions

Interstitial Lung Diseases

Practice Questions

Occupational Lung Diseases

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free